Filed in archive
Diagnostics, Methodologies and Instrumentation
by ruth on July 18, 2007

A Johnson & Johnson company - Veridex - has developed and manufactured a molecular-based lab test that will determine metastatic breast cancer: the GeneSearchâ„¢ Breast Lymph Node (BLN) Assay.
The good news is that, the FDA has just approved this test.
According to Daniel Schultz, M.D., director of the FDA's Center for Devices and Radiological Health:
"The GeneSearch BLN Assay offers a new approach to sentinel node testing. Results of this rapid test are available while patients are on the operating table, providing a way for some women to avoid a second operation."
Find more details from the full report.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/81405
Mr Wong
Vote for First Molecular-Based Lab Test to Detect Metastatic Breast Cancer, Approved by the FDA:
|
Rating: 7.50 out of 4 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







